Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Minor site revision updates: Revision: v3.3.4 added and Revision: v3.3.3 removed; these changes do not affect trial data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:34:32.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new history entry dated 2025-12-24 adds Contacts/Locations and Study Status (with version 37 appearing on 2025-12-22); the entry from 2025-11-28 was removed.
    Difference
    0.3%
    Check dated 2025-12-30T13:52:47.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Footer now lists Revision: v3.3.3; the HHS Vulnerability Disclosure section and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:46:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new study record for Divarasib in KRAS G12C NSCLC (KRAScendo 170) was added with eligibility, outcome measures, arms and interventions, study design, study description, study status, and study identification. The prior record for Divarasib in combination with other therapies (KRASendo 170) was removed.
    Difference
    0.7%
    Check dated 2025-12-01T22:55:35.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows an added revision tag v3.3.2 and the previous tag v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-24T20:53:11.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    A new version dated 2025-11-10 adds a Study Status update to the trial record, following an earlier 2025-11-07 entry. A banner notice about government funding lapses was removed from the page.
    Difference
    0.7%
    Check dated 2025-11-17T18:12:29.000Z thumbnail image

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.